Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: magazinearticle
|
Transthyretin amyloid cardiomyopathy: acoramidisManufacturing chemist (London : 1981), 2024-04, Vol.95 (4), p.30COPYRIGHT 2024 HPCi Media Ltd. ;ISSN: 0262-4230Digital Resources/Online E-Resources |
|
2 |
Material Type: magazinearticle
|
Gene therapy for cardiovascular diseaseHarvard heart letter, 2024-02Copyright © 2024 by Harvard University. All rights reserved. ;ISSN: 1051-5313 ;EISSN: 1943-510XFull text available |
|
3 |
Material Type: magazinearticle
|
Bayer acquires exclusive marketing rights for acoramidis in Europe from Eidos & BridgeBioPharmaBiz, 2024-03Copyright 2024 Saffron Media Pvt Ltd, distributed by Contify.comDigital Resources/Online E-Resources |
|
4 |
Material Type: magazinearticle
|
Bayer, AskBio announce first patient randomized in GenePHIT phase II trial of AB-1002 to treat congestive heart failurePharmaBiz, 2024-02Copyright 2024 Saffron Media Pvt Ltd, distributed by Contify.comDigital Resources/Online E-Resources |
|
5 |
Material Type: magazinearticle
|
US FDA grants fast track designation to Ionis & AstraZeneca's eplontersen for patients with transthyretin-mediated amyloid cardiomyopathyPharmaBiz, 2024-02Copyright 2024 Saffron Media Pvt Ltd, distributed by Contify.comDigital Resources/Online E-Resources |
|
6 |
Material Type: magazinearticle
|
How Neurobion Forte Can Help Manage Neuropathy Symptoms?Free Press Journal, 2024-04Copyright 2024 Indian National Press (Bombay) Pvt. Ltd., distributed by Contify.comDigital Resources/Online E-Resources |